Sign in

You're signed outSign in or to get full access.

Steven D. Kunzman

Chairman of the Board at Central Plains Bancshares
Board

About Steven D. Kunzman

Steven D. Kunzman is Chairman of the Board of Central Plains Bancshares (CPBI) and its bank subsidiary, a role he has held since 2017, following a 35+ year career at the bank including service as President and Chief Executive Officer from 2015 until the hiring of Dannel R. Garness on May 20, 2025 . He is age 65 (as of March 31, 2025) and has served on the board since 2010 . The board has determined he is not “independent” under Nasdaq rules due to his recent executive service .

Past Roles

OrganizationRoleTenureCommittees/Impact
Home Federal Savings (subsidiary) / CPBIPresident & CEO2015 – May 20, 2025Led operations and strategy; provided direct operational insight to the board .
CPBI / Home Federal SavingsChairman of the Board2017 – PresentBoard leadership; continued strategic oversight after CEO transition .
Home Federal Savings / CPBIEmployee35+ yearsDeep institutional knowledge .

External Roles

Company/OrganizationRoleTenureNotes
None disclosed in CPBI proxy statementsNo other public company directorships or external committee roles disclosed in 2024 and 2025 proxies .

Board Governance

  • Independence: Not independent (former executive within past 3 years) .
  • Board leadership: Roles split as of 2025 (Chair separate from CEO); previously combined Chair/CEO in 2024 -.
  • Committees: Not listed as a member of Audit, Compensation, or Nominating & Corporate Governance committees; those committees are fully independent and chaired by other directors .
  • Attendance: In FY2025 the board held 10 regular meetings; no director (including Mr. Kunzman) attended fewer than 75% of board/committee meetings during periods of service .
  • Annual meeting attendance: All but one director attended the 2024 Annual Meeting .
  • Independent director sessions: Independent directors meet periodically in executive session .

Committee assignments and roles

CommitteeMember?Chair?Notes
Board of DirectorsYesChairmanChair since 2017 .
Audit CommitteeNoAudit Committee: Oltean, Slater, Stump (Stump chair) .
Compensation CommitteeNoNaranjo, Oltean, Rerucha (chair), Schneider .
Nominating & Corporate GovernanceNoOltean, Rerucha, Slater (chair), Stump .

Fixed Compensation

Component ($)FY2024FY2025Notes
Base Salary230,056 241,502 As reported for Named Executive Officers (NEOs).
Director Fees (cash)11,000 11,000 Included in “All Other Compensation” breakdown.
Automobile Allowance (perquisite)10,321 9,385 Perquisite disclosed in “All Other Compensation.”
  • Executive benefits programs: Participates in defined benefit pension plan and a Supplemental Retirement Income Plan that provides $30,000 per year at retirement (120 monthly installments), with earlier termination reductions; also eligible for 401(k) participation (no match due to pension) -.

Performance Compensation

Component ($)FY2024FY2025Notes
Bonus (cash)1,930 1,871 Annual bonus.
Non-Equity Incentive Plan Compensation122,991 118,644 Based on company plan/pool (see metrics below).
Stock Awards (grant-date fair value)369,750 Restricted stock grants (see vesting terms below).
Option Awards (grant-date fair value)290,189 Stock options granted under 2024 Equity Plan.
All Other Compensation (total)30,050 36,845 See fixed components table for detail.

Performance and incentive structure (key design features)

  • Annual bonus funding mechanic (bank-level): Requires achieving a minimum Return on Assets (ROA); 35% of any amount above the minimum is set aside in a pool, allocated 65% to senior managers and 35% to managers, with board discretion on individual percentages .
  • Equity plan architecture (2024 Equity Incentive Plan): Up to 578,313 shares authorized (10% options = 413,081; 4% full value awards = 165,232), with minimum 1-year vesting for at least 95% of awards; options priced at or above fair market value; no option repricing or cash buyouts without shareholder approval; dividends on unvested RS withheld until vest; awards subject to company clawback and hedging/pledging policy restrictions; double-trigger vesting upon change in control (CIC) unless awards not assumed -.
  • Director equity grants (board-wide context): Upon plan approval in 2024, each non-employee director received a one-time grant of 8,261 restricted shares and 20,654 options, vesting 20% per year over 5 years (recognizing efforts during conversion); options 10-year term at grant-date FMV -.

Outstanding equity and vesting detail (Mr. Kunzman)

Award TypeQuantityStatus/Terms
Unvested Restricted Stock25,000Market value $369,750 at $14.92 as of 3/31/2025 .
Stock Options50,000Unexercisable as of 3/31/2025; $14.79 strike; expiring 1/10/2035 .

Other Directorships & Interlocks

CompanyExchangeRoleCommitteesInterlocks/Conflicts
None disclosedNo other public company board service disclosed in CPBI proxies .

Expertise & Qualifications

  • Long-tenured community bank operator (35+ years), former CEO and current Chair; brings operational management and strategic insight to board deliberations .
  • Board identifies his experience as providing insight into operations, employee management, and corporate strategy; serves as a liaison on strategy from prior executive leadership to the board .

Equity Ownership

Ownership DetailAmountNotes
Total Beneficial Ownership55,855 shares (1.3%) Percent based on 4,222,978 shares outstanding .
Direct/Indirect BreakdownIncludes 7,500 (IRA), 7,500 (spouse), 1,956 (ESOP), and 25,000 unvested restricted stock .As disclosed in footnotes.
Options50,000 unexercisable options @ $14.79, expiring 1/10/2035 .Unexercisable as of 3/31/2025.
Pledging/HedgingPlan subjects awards to hedging/pledging restrictions; no pledging by Mr. Kunzman disclosed .

Governance Assessment

  • Independence and committee balance: Mr. Kunzman is not independent and does not sit on key independent committees (Audit, Compensation, Nominating), which aligns with best practice given his recent executive role but concentrates influence in a non-independent chair .
  • Leadership structure trend: Board moved from combined Chair/CEO in 2024 to a split structure in 2025, improving independent oversight; Mr. Kunzman remains non-independent Chair - .
  • Attendance and engagement: Board met 10 times in FY2025; all directors, including Mr. Kunzman, met the 75%+ attendance threshold; all but one attended the 2024 annual meeting .
  • Pay and alignment: As a former CEO/NEO in FY2025, his pay included meaningful equity (25,000 RS; 50,000 options) and non-equity incentive tied to the ROA-based bonus framework, supporting alignment but reflecting executive, not purely director, compensation status - .
  • Clawback and equity controls: 2024 Equity Plan incorporates clawbacks, no option repricing, minimum vesting, and double-trigger CIC vesting—positive governance features -.
  • Related-party safeguards: No related-party transactions >$120,000 since April 1, 2022; board reviewed customary director banking relationships (e.g., loans/deposits) in independence determinations .

Employment & Contracts (historical context relevant to conflicts/retention)

  • Prior CEO employment agreement (2024 proxy): Base salary $227,000 with severance equal to remaining term (non‑CIC) and 3x salary+highest bonus on CIC (double-trigger), one‑year non‑compete/non‑solicit; company-paid COBRA up to 18 months upon qualifying termination -.
  • Current CEO agreements (context): 2025 proxy details new CEO contract (Garness) and CIC agreements for other executives; board uses external comp consultant (Newcleus) in 2025 - .

Director Compensation (Board-wide context for alignment)

ItemFY2025 (typical non-employee director)
Cash Fees$19,500–$21,000 per director .
Stock Awards (RS)$118,958 grant-date value; 8,261 shares; 5-year 20% annual vest .
Option Awards$110,054 grant-date value; 20,654 options; 10-year term; 5-year 20% annual vest -.

Note: Director fees paid to Mr. Kunzman are included in the NEO Summary Compensation Table (e.g., $11,000 in FY2025), reflecting his transitional “former CEO/Chair” status rather than typical non-employee director compensation .

Risk Indicators & Red Flags

  • Non-independent chair: Concentrates authority; mitigated by independent committees and split CEO/Chair as of 2025 -.
  • Large initial director equity awards (board-wide, 2024 plan): Enhances alignment but increases dilution and may influence director independence perceptions; vesting over 5 years and clawbacks partly mitigate -.
  • Golden parachute history (as CEO in 2024 proxy): 3x salary+bonus CIC terms (historical); typical shareholder sensitivity around such multiples -.
  • Section 16 compliance: No delinquencies reported for FY2025—positive signal .

Related-Party Transactions

  • None requiring disclosure >$120,000 since April 1, 2022; ordinary-course banking relationships noted in independence review (loans to other directors, deposit accounts) .

Compensation Committee Analysis (process)

  • 2025: Compensation Committee used Newcleus Compensation Advisors for peer benchmarking and executive comp evaluation .
  • 2024: No compensation consultant used .

Say-on-Pay & Shareholder Feedback

  • Not disclosed in the proxies reviewed (company became public via mutual-to-stock conversion; say-on-pay history not provided in these filings) .

Summary Implications for Investors

  • Governance strengths: Split CEO/Chair in 2025; fully independent key committees; strong equity plan safeguards (clawbacks, no repricing, double-trigger CIC); solid attendance - -.
  • Watch points: Non-independent chair; substantial equity pay across board (from 2024 plan) and Mr. Kunzman’s transitional executive-level equity grants; historical CIC severance multiple as CEO (context) - - -.
  • Alignment: Meaningful beneficial ownership (1.3%, including unvested equity), with options struck near mid-teens and time-based vesting over five years .